Daljeet S Rai, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 18
- 3 carriers
- Offices
- 4
Offices
4 locations · University Healthcare Alliance · Indian Health Center of Santa Clara Valley
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
18 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rai’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
18 of 18 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G53264 · Current
Licensed to practise in California · since 1984 · expires 2027-12-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$33,938
Medicare paid this office $33,938 for 107 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 40 | $8,741 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,058 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,390 | $154 |
| Long return visit (40+ min) | 11 | $2,653 | $156 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,505 | $104 |
See all 10 services
| Return visit (30+ min) | 40 | $8,741 | $104 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $7,058 | $102 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $3,390 | $154 |
| Long return visit (40+ min) | 11 | $2,653 | $156 |
| Hospital discharge day management, more than 30 minutes | 23 | $2,505 | $104 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,449 | $153 |
| Influenza vaccine split virus, preservative free | 13 | $1,064 | $82 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 29 | $777 | $15 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $741 | $57 |
| Administration of influenza virus vaccine | 13 | $497 | $38 |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
107 Original Medicare patients in 2024. Average age 74 · Under 65 12% · 85 and older 20% · Women 53% · Also on Medicaid 34% · Health risk score 2.05. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 40% · Coronary heart disease 34% · Chronic kidney disease 30% · Atrial fibrillation 29% · Heart failure 25% · Depression 21% · Dementia 20% · Cancer 15% · COPD 15% · Stroke 15%.
The office billed $133,598, Medicare allowed $44,988 and paid $33,938; for 391 services of 30 kinds; $1,861 of it was for drugs given in the office and $32,076 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 107 | 391 | 74 | 2.05 | $133,598 | $33,938 |
| 2023 | 109 | 366 | 76 | 2.00 | $128,629 | $34,787 |
| 2022 | 129 | 387 | 75 | 2.04 | $147,302 | $39,597 |
| 2021 | 127 | 447 | 75 | 2.19 | $174,530 | $50,124 |
| 2020 | 141 | 600 | 75 | 2.33 | $244,210 | $62,385 |
| 2019 | 163 | 457 | 75 | 2.15 | $157,219 | $37,941 |
| 2018 | 157 | 420 | 75 | 2.24 | $152,334 | $39,252 |
| 2017 | 209 | 557 | 74 | 2.30 | $179,486 | $47,039 |
| 2016 | 154 | 387 | 76 | 2.55 | $132,781 | $35,187 |
| 2015 | 134 | 319 | 73 | 1.62 | $93,669 | $29,804 |
| 2014 | 174 | 423 | 74 | 2.10 | $114,142 | $37,663 |
| 2013 | 178 | 419 | 75 | 1.93 | $89,515 | $40,022 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 38 | $10,349 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $4,989 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $3,790 | $152 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,806 | $156 |
| Hospital discharge day management, more than 30 minutes | 18 | $1,872 | $104 |
| Long return visit (40+ min) | 11 | $1,819 | $152 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,604 | $70 |
| Short return visit (20+ min) | 11 | $1,075 | $77 |
| Influenza vaccine split virus, preservative free | 14 | $1,000 | $71 |
| Administration of influenza virus vaccine | 13 | $480 | $37 |
2022: 8 services
| Return visit (30+ min) | 47 | $11,583 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $9,762 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,543 | $179 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 12 | $1,901 | $158 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,101 | $65 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,064 | $97 |
| Influenza vaccine split virus, preservative free | 12 | $819 | $68 |
| Administration of influenza virus vaccine | 12 | $448 | $37 |
2021: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $21,717 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $10,365 | $196 |
| Return visit (30+ min) | 32 | $6,094 | $107 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 15 | $2,454 | $164 |
| Hospital discharge day management, 30 minutes or less | 29 | $2,013 | $69 |
| Short return visit (20+ min) | 15 | $1,401 | $88 |
2020: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $33,391 | $105 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $13,367 | $200 |
| Return visit (30+ min) | 26 | $3,871 | $86 |
| Hospital discharge day management, 30 minutes or less | 32 | $2,631 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,113 | $70 |
| Short return visit (20+ min) | 13 | $1,143 | $57 |
| Influenza vaccine split virus, preservative free | 12 | $726 | $60 |
| Administration of influenza virus vaccine | 12 | $251 | $21 |
2019: 9 services
| Return visit (30+ min) | 48 | $9,837 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $7,861 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,694 | $178 |
| Hospital discharge day management, 30 minutes or less | 36 | $2,306 | $64 |
| Short return visit (20+ min) | 29 | $2,217 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,723 | $66 |
| Influenza vaccine split virus, preservative free | 16 | $876 | $55 |
| Administration of influenza virus vaccine | 16 | $328 | $21 |
| Administration of pneumococcal vaccine | 12 | $246 | $21 |
2018: 9 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,368 | $182 |
| Return visit (30+ min) | 40 | $6,992 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $6,460 | $94 |
| Hospital discharge day management, 30 minutes or less | 33 | $2,273 | $67 |
| Long return visit (40+ min) | 11 | $1,971 | $116 |
| Short return visit (20+ min) | 19 | $1,500 | $60 |
| Influenza vaccine split virus, preservative free | 15 | $780 | $52 |
| Administration of influenza virus vaccine | 17 | $437 | $26 |
| Administration of pneumococcal vaccine | 11 | $283 | $26 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $11,592 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $10,645 | $175 |
| Return visit (30+ min) | 42 | $6,782 | $86 |
| Hospital discharge day management, 30 minutes or less | 71 | $4,704 | $66 |
| Long return visit (40+ min) | 20 | $3,182 | $118 |
| Short return visit (20+ min) | 23 | $1,384 | $51 |
2016: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $8,703 | $178 |
| Return visit (30+ min) | 31 | $6,288 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,204 | $93 |
| Hospital discharge day management, 30 minutes or less | 43 | $2,827 | $66 |
| Short return visit (20+ min) | 27 | $2,098 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,222 | $64 |
| Administration of influenza virus vaccine | 11 | $412 | $32 |
2015: 9 services
| Return visit (30+ min) | 33 | $6,250 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 27 | $4,970 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $3,202 | $97 |
| Hospital discharge day management, 30 minutes or less | 38 | $2,622 | $69 |
| Short return visit (20+ min) | 30 | $2,437 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,287 | $67 |
| Pneumococcal vaccine, 13-valent | 13 | $2,168 | $167 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 11 | $2,058 | $187 |
| Administration of pneumococcal vaccine | 13 | $413 | $32 |
2014: 7 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $9,058 | $178 |
| Return visit (30+ min) | 32 | $6,174 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $6,100 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,866 | $64 |
| Hospital discharge day management, 30 minutes or less | 60 | $4,058 | $65 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 18 | $3,345 | $186 |
| Short return visit (20+ min) | 26 | $2,219 | $62 |
2013: 6 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,429 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $7,608 | $90 |
| Return visit (30+ min) | 35 | $7,252 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,288 | $62 |
| Hospital discharge day management, 30 minutes or less | 35 | $2,232 | $64 |
| Short return visit (20+ min) | 19 | $1,287 | $56 |
Medicaid work
$151,494 in 2024
Medicaid paid $151,494 for 1,252 billed services this clinician did in 2024, up to 86 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 579 | $146,110 |
| Short return visit (20+ min) | 566 | $3,895 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 54 | $866 |
| Return visit (30+ min) | 53 | $623 |
| 2024 | 1,252 | 4 | 86 | $151,494 |
| 2023 | 1,923 | 5 | 111 | $204,936 |
| 2022 | 2,248 | 9 | 115 | $186,475 |
| 2021 | 3,575 | 12 | 147 | $275,519 |
| 2020 | 2,167 | 11 | 109 | $145,172 |
| 2019 | 2,511 | 10 | 155 | $275,150 |
| 2018 | 1,812 | 11 | 134 | $226,351 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 855 | $200,793 |
| Short return visit (20+ min) | 825 | $2,243 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 59 | $945 |
| Return visit (30+ min) | 171 | $642 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $312 |
2022
| Clinic visit/encounter, all-inclusive | 777 | $179,370 |
| Short return visit (20+ min) | 883 | $2,353 |
| 1ST HOSP IP/OBS HIGH 75 | 54 | $1,970 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 113 | $1,831 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 14 | $334 |
| Short return visit | 150 | $300 |
| Return visit (30+ min) | 50 | $257 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 157 | $60 |
| Service | 50 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,073 | $254,236 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 262 | $4,793 |
| 1ST HOSP IP/OBS HIGH 75 | 114 | $4,604 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 51 | $3,401 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 85 | $2,168 |
| Service | 49 | $2,108 |
| Short return visit (20+ min) | 683 | $1,895 |
| Prenatal care, at-risk enhanced service; antepartum management | 18 | $931 |
| Short return visit | 372 | $833 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 43 | $335 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 556 | $214 |
| Service | 269 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 583 | $129,618 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 446 | $6,336 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 45 | $2,814 |
| 1ST HOSP IP/OBS HIGH 75 | 83 | $2,647 |
| Service | 32 | $1,377 |
| Short return visit (20+ min) | 413 | $975 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 49 | $919 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 40 | $300 |
| Short return visit | 105 | $108 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 257 | $79 |
| Service | 114 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,147 | $262,026 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 124 | $7,755 |
| Short return visit (20+ min) | 598 | $2,330 |
| Short return visit | 178 | $935 |
| Service | 15 | $645 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $601 |
| TD VACC NO PRESV 7 YRS+ IM | 14 | $358 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 31 | $352 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 325 | $147 |
| Service | 64 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 906 | $203,642 |
| Short return visit (20+ min) | 438 | $9,227 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 72 | $4,467 |
| Service | 97 | $4,174 |
| 1ST HOSP IP/OBS HIGH 75 | 45 | $1,473 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 56 | $1,269 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 41 | $1,183 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 31 | $545 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $180 |
| Short return visit | 14 | $109 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 99 | $83 |
Drugs they prescribed that Part D paid
$50,833
Pharmacies billed $50,833 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 755) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
674 generic and fewer than 11 brand-name prescriptions · $50,833 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 12 | $10,887 | $907 |
| Duloxetine | 16 | $864 | $54 |
| Atorvastatin | 81 | $773 | $10 |
| Gabapentin | 12 | $440 | $37 |
| Losartan | 45 | $426 | $9 |
See all 19 drugs
| Eliquis | 12 | $10,887 | $907 |
| Duloxetine | 16 | $864 | $54 |
| Atorvastatin | 81 | $773 | $10 |
| Gabapentin | 12 | $440 | $37 |
| Losartan | 45 | $426 | $9 |
| Levothyroxine | 36 | $319 | $9 |
| Omeprazole | 13 | $294 | $23 |
| Amlodipine Besylate | 42 | $268 | $6 |
| Rosuvastatin | 20 | $210 | $11 |
| Oxybutynin Chloride Er | 13 | $196 | $15 |
| Simvastatin | 24 | $189 | $8 |
| Lisinopril | 39 | $180 | $5 |
| Metoprolol | 13 | $178 | $14 |
| Finasteride | 11 | $149 | $14 |
| Tamsulosin | 21 | $139 | $7 |
| Metformin | 18 | $107 | $6 |
| Hydrochlorothiazide | 23 | $104 | $5 |
| Benazepril | 13 | $99 | $8 |
| Lorazepam | 12 | $23 | $2 |
Year by year
| 2024 | 755 | 94 | 0% (0) | None | $50,833 |
| 2023 | 748 | 93 | None | None | $50,071 |
| 2022 | 757 | 113 | None | None | $54,305 |
| 2021 | 705 | 103 | None | None | $40,037 |
| 2020 | 864 | 126 | None | 13% | $42,508 |
| 2019 | 820 | 153 | 2% (18) | None | $33,980 |
| 2018 | 898 | 167 | 4% (36) | None | $51,731 |
| 2017 | 765 | 132 | 3% (21) | None | $41,751 |
| 2016 | 958 | 102 | 2% (16) | None | $54,098 |
| 2015 | 1,008 | 123 | 3% (28) | 16% | $53,461 |
| 2014 | 901 | 99 | 2% (14) | 19% | $52,986 |
| 2013 | 944 | 117 | 4% (38) | 18% | $55,828 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Atorvastatin | 84 | $1,064 | $13 |
| Duloxetine | 20 | $867 | $43 |
| Losartan | 44 | $549 | $12 |
| Gabapentin | 16 | $435 | $27 |
| Levothyroxine | 30 | $352 | $12 |
| Tamsulosin | 26 | $340 | $13 |
| Lisinopril | 42 | $324 | $8 |
| Amlodipine Besylate | 46 | $297 | $6 |
| Rosuvastatin | 14 | $168 | $12 |
| Metformin | 20 | $156 | $8 |
| Hydrochlorothiazide | 25 | $153 | $6 |
| Simvastatin | 13 | $119 | $9 |
| Trazodone | 14 | $89 | $6 |
| Meloxicam | 21 | $59 | $3 |
| Paroxetine | 11 | $44 | $4 |
| Lorazepam | 12 | $24 | $2 |
2022: 17 drugs
| Atorvastatin | 90 | $1,209 | $13 |
| Losartan | 51 | $558 | $11 |
| Levothyroxine | 28 | $470 | $17 |
| Gabapentin | 21 | $393 | $19 |
| Lisinopril | 41 | $325 | $8 |
| Duloxetine | 14 | $314 | $22 |
| Tamsulosin | 31 | $305 | $10 |
| Amlodipine Besylate | 33 | $280 | $8 |
| Famotidine | 15 | $195 | $13 |
| Omeprazole | 11 | $170 | $15 |
| Hydrochlorothiazide | 29 | $149 | $5 |
| Metformin Hcl Er | 12 | $148 | $12 |
| Simvastatin | 18 | $147 | $8 |
| Metformin | 14 | $122 | $9 |
| Zolpidem | 12 | $89 | $7 |
| Atenolol | 13 | $73 | $6 |
| Sertraline | 13 | $59 | $5 |
2021: 19 drugs
| Eliquis | 13 | $10,665 | $820 |
| Atorvastatin | 83 | $901 | $11 |
| Losartan | 50 | $626 | $13 |
| Gabapentin | 17 | $524 | $31 |
| Levothyroxine | 20 | $413 | $21 |
| Lisinopril | 53 | $347 | $7 |
| Benazepril | 14 | $246 | $18 |
| Amlodipine Besylate | 30 | $210 | $7 |
| Famotidine | 14 | $176 | $13 |
| Zolpidem | 24 | $156 | $6 |
| Metformin Hcl Er | 11 | $148 | $13 |
| Escitalopram | 17 | $130 | $8 |
| Tamsulosin | 14 | $128 | $9 |
| Hydrochlorothiazide | 25 | $127 | $5 |
| Metformin | 15 | $94 | $6 |
| Atenolol | 13 | $92 | $7 |
| Metoprolol | 11 | $85 | $8 |
| Furosemide | 15 | $71 | $5 |
| Simvastatin | 11 | $39 | $4 |
2020: 24 drugs
| Eliquis | 13 | $9,357 | $720 |
| Farxiga | 16 | $5,328 | $333 |
| Losartan | 54 | $1,100 | $20 |
| Atorvastatin | 66 | $1,001 | $15 |
| Pravastatin | 24 | $847 | $35 |
| Levothyroxine | 33 | $831 | $25 |
| Simvastatin | 19 | $447 | $24 |
| Gabapentin | 17 | $443 | $26 |
| Benazepril | 15 | $335 | $22 |
| Tamsulosin | 23 | $333 | $14 |
| Lisinopril | 43 | $309 | $7 |
| Escitalopram | 25 | $289 | $12 |
| Amlodipine Besylate | 44 | $268 | $6 |
| Clopidogrel | 15 | $245 | $16 |
| Omeprazole | 18 | $222 | $12 |
| Metformin Hcl Er | 11 | $199 | $18 |
| Metformin | 20 | $169 | $8 |
| Glipizide Er | 13 | $168 | $13 |
| Famotidine | 16 | $150 | $9 |
| Zolpidem | 18 | $132 | $7 |
| Hydrochlorothiazide | 13 | $108 | $8 |
| Trazodone | 18 | $92 | $5 |
| Metoprolol | 16 | $89 | $6 |
| Lorazepam | 14 | $63 | $4 |
2019: 21 drugs
| Atorvastatin | 74 | $1,416 | $19 |
| Losartan | 48 | $780 | $16 |
| Levothyroxine | 45 | $659 | $15 |
| Tamsulosin | 26 | $620 | $24 |
| Amlodipine Besylate | 40 | $468 | $12 |
| Digox | 12 | $464 | $39 |
| Pravastatin | 21 | $447 | $21 |
| Gabapentin | 15 | $412 | $27 |
| Fluticasone Propionate | 17 | $340 | $20 |
| Simvastatin | 23 | $327 | $14 |
| Metformin | 30 | $254 | $8 |
| Hydrocodone-Acetaminophen | 16 | $240 | $15 |
| Benazepril | 13 | $233 | $18 |
| Donepezil | 18 | $232 | $13 |
| Ranitidine | 11 | $232 | $21 |
| Escitalopram | 21 | $210 | $10 |
| Lisinopril | 22 | $191 | $9 |
| Fluoxetine | 12 | $152 | $13 |
| Atenolol | 14 | $121 | $9 |
| Hydrochlorothiazide | 15 | $119 | $8 |
| Metformin Hcl Er | 11 | $114 | $10 |
2018: 22 drugs
| Spiriva | 13 | $3,574 | $275 |
| Atorvastatin | 83 | $1,647 | $20 |
| Levothyroxine | 67 | $842 | $13 |
| Hydrocodone-Acetaminophen | 19 | $655 | $34 |
| Losartan | 47 | $596 | $13 |
| Amlodipine Besylate | 42 | $577 | $14 |
| Tamsulosin | 22 | $475 | $22 |
| Pravastatin | 17 | $446 | $26 |
| Metformin | 27 | $407 | $15 |
| Gabapentin | 11 | $372 | $34 |
| Fluticasone Propionate | 26 | $361 | $14 |
| Ranitidine | 23 | $223 | $10 |
| Bupropion | 12 | $207 | $17 |
| Lisinopril | 24 | $187 | $8 |
| Simvastatin | 18 | $173 | $10 |
| Escitalopram | 12 | $156 | $13 |
| Benazepril | 11 | $129 | $12 |
| Hydrochlorothiazide | 17 | $115 | $7 |
| Jantoven | 11 | $113 | $10 |
| Sertraline | 12 | $93 | $8 |
| Furosemide | 14 | $87 | $6 |
| Lorazepam | 13 | $40 | $3 |
2017: 20 drugs
| Atorvastatin | 68 | $1,421 | $21 |
| Levothyroxine | 68 | $1,116 | $16 |
| Losartan | 49 | $587 | $12 |
| Metformin | 26 | $333 | $13 |
| Warfarin | 15 | $320 | $21 |
| Amlodipine Besylate | 27 | $288 | $11 |
| Pravastatin | 15 | $285 | $19 |
| Fluticasone Propionate | 16 | $241 | $15 |
| Sertraline | 22 | $211 | $10 |
| Benazepril | 17 | $169 | $10 |
| Escitalopram | 12 | $158 | $13 |
| Lisinopril | 24 | $146 | $6 |
| Gabapentin | 13 | $120 | $9 |
| Omeprazole | 12 | $114 | $9 |
| Bupropion | 11 | $112 | $10 |
| Jantoven | 14 | $109 | $8 |
| Hydrochlorothiazide | 22 | $105 | $5 |
| Furosemide | 18 | $90 | $5 |
| Simvastatin | 12 | $81 | $7 |
| Lorazepam | 11 | $24 | $2 |
2016: 30 drugs
| Advair Diskus | 24 | $10,455 | $436 |
| Spiriva | 15 | $5,128 | $342 |
| Duloxetine | 16 | $1,924 | $120 |
| Proair Hfa | 15 | $1,258 | $84 |
| Atorvastatin | 49 | $1,008 | $21 |
| Levothyroxine | 52 | $912 | $18 |
| Losartan | 37 | $434 | $12 |
| Fluticasone Propionate | 25 | $294 | $12 |
| Amlodipine Besylate | 29 | $279 | $10 |
| Potassium Chloride | 18 | $272 | $15 |
| Pravastatin | 18 | $270 | $15 |
| Doxazosin Mesylate | 11 | $241 | $22 |
| Omeprazole | 19 | $228 | $12 |
| Benazepril | 23 | $226 | $10 |
| Lisinopril | 40 | $222 | $6 |
| Metoprolol | 14 | $220 | $16 |
| Spironolactone | 15 | $187 | $12 |
| Pantoprazole | 19 | $141 | $7 |
| Gabapentin | 25 | $139 | $6 |
| Furosemide | 38 | $129 | $3 |
| Metformin | 23 | $129 | $6 |
| Hydrochlorothiazide | 20 | $118 | $6 |
| Warfarin | 12 | $115 | $10 |
| Atenolol | 19 | $115 | $6 |
| Mirtazapine | 18 | $109 | $6 |
| Simvastatin | 13 | $93 | $7 |
| Escitalopram | 13 | $92 | $7 |
| Sertraline | 12 | $64 | $5 |
| Metoprolol | 11 | $36 | $3 |
| Citalopram Hbr | 11 | $34 | $3 |
2015: 28 drugs
| Lyrica | 12 | $5,069 | $422 |
| Spiriva | 11 | $3,488 | $317 |
| Proair Hfa | 16 | $1,180 | $74 |
| Atorvastatin | 57 | $1,112 | $20 |
| Tamsulosin | 23 | $539 | $23 |
| Levothyroxine | 36 | $481 | $13 |
| Losartan | 40 | $428 | $11 |
| Hydrocodone-Acetaminophen | 18 | $375 | $21 |
| Fluticasone Propionate | 21 | $352 | $17 |
| Warfarin | 18 | $344 | $19 |
| Lisinopril | 51 | $309 | $6 |
| Doxazosin Mesylate | 13 | $289 | $22 |
| Potassium Chloride | 18 | $285 | $16 |
| Amlodipine Besylate | 39 | $275 | $7 |
| Benazepril | 40 | $261 | $7 |
| Furosemide | 58 | $221 | $4 |
| Losartan-Hydrochlorothiazide | 13 | $219 | $17 |
| Pantoprazole | 20 | $183 | $9 |
| Omeprazole | 17 | $130 | $8 |
| Alendronate | 15 | $125 | $8 |
| Atenolol | 13 | $119 | $9 |
| Simvastatin | 16 | $115 | $7 |
| Hydrochlorothiazide | 17 | $103 | $6 |
| Metformin | 12 | $100 | $8 |
| Gemfibrozil | 11 | $91 | $8 |
| Glipizide | 14 | $85 | $6 |
| Metoprolol | 18 | $77 | $4 |
| Citalopram Hbr | 11 | $38 | $3 |
2014: 27 drugs
| Oxytrol | 12 | $5,044 | $420 |
| Spiriva | 13 | $3,807 | $293 |
| Proair Hfa | 22 | $1,324 | $60 |
| Metoprolol | 14 | $773 | $55 |
| Atorvastatin | 37 | $647 | $17 |
| Losartan | 46 | $621 | $14 |
| Fosinopril | 16 | $530 | $33 |
| Fluticasone Propionate | 35 | $487 | $14 |
| Levothyroxine | 38 | $449 | $12 |
| Metformin | 16 | $333 | $21 |
| Phenobarbital | 12 | $292 | $24 |
| Amlodipine Besylate | 31 | $267 | $9 |
| Simvastatin | 17 | $267 | $16 |
| Potassium Chloride | 15 | $253 | $17 |
| Benazepril | 26 | $230 | $9 |
| Lisinopril | 31 | $223 | $7 |
| Tamsulosin | 14 | $203 | $14 |
| Hydrochlorothiazide | 44 | $202 | $5 |
| Alendronate | 17 | $168 | $10 |
| Clonidine | 16 | $159 | $10 |
| Warfarin | 12 | $142 | $12 |
| Omeprazole | 17 | $133 | $8 |
| Fluoxetine | 16 | $119 | $7 |
| Glipizide | 12 | $110 | $9 |
| Gemfibrozil | 11 | $108 | $10 |
| Furosemide | 28 | $90 | $3 |
| Citalopram Hbr | 12 | $45 | $4 |
2013: 25 drugs
| Spiriva | 18 | $4,882 | $271 |
| Levemir | 12 | $4,621 | $385 |
| Atorvastatin | 28 | $942 | $34 |
| Proair Hfa | 13 | $923 | $71 |
| Losartan | 36 | $873 | $24 |
| Fluticasone Propionate | 27 | $629 | $23 |
| Fosinopril | 12 | $490 | $41 |
| Simvastatin | 39 | $442 | $11 |
| Levothyroxine | 38 | $404 | $11 |
| Lisinopril | 30 | $363 | $12 |
| Amlodipine Besylate | 37 | $360 | $10 |
| Omeprazole | 30 | $341 | $11 |
| Alendronate | 27 | $286 | $11 |
| Hydrocodone-Acetaminophen | 20 | $284 | $14 |
| Tamsulosin | 17 | $260 | $15 |
| Lorazepam | 24 | $259 | $11 |
| Metformin | 17 | $252 | $15 |
| Hydrochlorothiazide | 28 | $187 | $7 |
| Fluoxetine | 13 | $169 | $13 |
| Benazepril | 25 | $167 | $7 |
| Pravastatin | 14 | $166 | $12 |
| Glipizide | 16 | $150 | $9 |
| Citalopram Hbr | 17 | $116 | $7 |
| Furosemide | 25 | $101 | $4 |
| Warfarin | 13 | $96 | $7 |
Money from drug and device companies
$17 in 2023
| 2023 | 1 | 1 | None | $17 |
| 2021 | 1 | 1 | None | $12 |
| 2019 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Arexvy | $17 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2023-09-01 | Arexvy | $17 |
See earlier years (2021, 2019)
2021: $12
| Roche Diagnostics | Harmony Products | $12 | 1 payment
|
2019: $14
| Roche Diagnostics | Rs Harmony Test Related Products | $14 | 1 payment
|
Professional record
- NPI
- 1174609788
- Licence
- CA G53264California G53264: Current · expires 2027-12-31
- Trained
- University of Southern California Keck School of Medicine, 1983
- Group
- University Healthcare Alliance · Indian Health Center of Santa Clara Valley
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr, Ste 210, San Jose, CA, 95128
- NPI first listed
- 2006-10-27
- NPI last updated
- 2012-02-02
This is when the NPI record was last certified, not a medical board exam.